期刊
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
卷 34, 期 4, 页码 775-783出版社
AMER CHEMICAL SOC
DOI: 10.1021/jasms.3c00069
关键词
-
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is a method to study the solvent accessibility and conformational dynamics of proteins. In this study, HDX-MS was used to determine the binding sites of Affimer reagents on monoclonal antibodies trastuzumab and pertuzumab. The results showed that the affimer binding led to significant protection in the Fab region of the antibodies. The binding sites of the affimer reagents were mainly located in the CDR2 of the heavy chain of the antibodies, as revealed by bottom-up HDX-MS experiments.
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is a method to probe the solvent accessibility and conformational dynamics of a protein or a protein-ligand complex with respect to exchangeable amide hydrogens. Here, we present the application of HDX-MS to determine the binding sites of Affimer reagents to the monoclonal antibodies trastuzumab and pertuzumab, respectively. Intact and subunit level HDX-MS analysis of antibody-affimer complexes showed significant protection from HDX in the antibody Fab region upon affimer binding. Bottom-up HDX-MS experiments including online pepsin digestion revealed that the binding sites of the affimer reagents were mainly located in the complementarity-determining region (CDR) 2 of the heavy chain of the respective antibodies. Three-dimensional models of the binding interaction between the affimer reagents and the antibodies were built by homology modeling and molecular docking based on the HDX data.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据